[Naproxen--a new antiphlogistic].
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates; D007213:Indomethacin
Naproxen--ett nytt antiflogistikum